BKYI Logo

BIO-key International, Inc. (BKYI) Insider Trading Activity

NASDAQ$0.833
Market Cap
$4.84M
Sector
Industrials
Industry
Security & Protection Services
Rank in Sector
248 of 505
Rank in Industry
14 of 21

BKYI Insider Trading Activity

BKYI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$0
0
–
Sells
$0
0
–

Related Transactions

About BIO-key International, Inc.

BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Wall, New Jersey.

Insider Activity of BIO-key International, Inc.

Over the last 12 months, insiders at BIO-key International, Inc. have bought $0 and sold $0 worth of BIO-key International, Inc. stock.

On average, over the past 5 years, insiders at BIO-key International, Inc. have bought $74,822 and sold $0 worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 20,000 shares for transaction amount of $3,600 was made by DEPASQUALE MICHAEL W (Chief Executive Officer) on 2023‑12‑01.

List of Insider Buy and Sell Transactions, BIO-key International, Inc.

2023-12-01PurchaseDEPASQUALE MICHAEL WChief Executive Officer
20,000
0.1375%
$0.18
$3,600
-49.22%
2023-11-30PurchaseSullivan James DavidChief Legal Officer
20,000
0.102%
$0.17
$3,300
-56.07%
2023-11-27PurchaseSullivan James DavidChief Legal Officer
10,003
0.0726%
$0.16
$1,644
-40.97%
2023-11-24PurchaseSullivan James DavidChief Legal Officer
29,668
0.2105%
$0.16
$4,862
-44.12%
2023-10-30PurchaseSullivan James DavidChief Legal Officer
285,100
3.2231%
$0.17
$49,893
-37.15%
2023-10-30PurchaseDEPASQUALE MICHAEL WChief Executive Officer
165,000
1.8653%
$0.17
$28,875
-37.15%
2023-09-15PurchaseSullivan James DavidChief Legal Officer
5,000
0.057%
$0.55
$2,748
-79.59%
2023-09-13PurchaseDEPASQUALE MICHAEL WChief Executive Officer
5,000
0.0525%
$0.52
$2,575
-79.14%
2023-09-12PurchaseDEPASQUALE MICHAEL WChief Executive Officer
100
0.001%
$0.51
$51
-79.87%
2023-09-11PurchaseSullivan James DavidChief Legal Officer
9,000
0.0968%
$0.53
$4,750
-79.87%
2023-08-31PurchaseSullivan James DavidChief Legal Officer
5,000
0.0563%
$0.55
$2,750
-78.76%
2023-06-16PurchaseDEPASQUALE MICHAEL WChief Executive Officer
5,000
0.0541%
$0.71
$3,575
-77.66%
2022-09-15PurchaseDEPASQUALE MICHAEL WChief Executive Officer
1,000
0.0123%
$1.69
$1,688
-54.44%
2022-09-14PurchaseSullivan James DavidChief Legal Officer
2,650
0.0329%
$1.62
$4,293
-51.88%
2022-09-14PurchaseDEPASQUALE MICHAEL WChief Executive Officer
1,269
0.0156%
$1.60
$2,030
-51.88%
2022-09-12PurchaseSullivan James DavidChief Legal Officer
968
0.0119%
$1.57
$1,520
-50.96%
2022-09-08PurchaseSullivan James DavidChief Legal Officer
2,377
0.0284%
$1.52
$3,613
-50.64%
2022-08-24PurchaseSullivan James DavidChief Legal Officer
5,005
0.0616%
$1.72
$8,584
-54.39%
2022-06-14PurchaseDEPASQUALE MICHAEL WChief Executive Officer
2,000
0.0244%
$1.66
$3,320
-49.40%
2022-06-14PurchaseSullivan James DavidChief Legal Officer
3,416
0.0424%
$1.69
$5,764
-49.40%
Total: 81

Insider Historical Profitability

<0.0001%
Kwok Fong WongManaging Director, BIO-key HK
4390708
75.5191%
$3.66M220
Colatosti Thomas J.director
1134405
19.5115%
$944,959.37160
FODERO RANDYVP, Sales
482800
8.304%
$402,172.4020
Sullivan James DavidChief Legal Officer
388171
6.6764%
$323,346.44180
<0.0001%
DEPASQUALE MICHAEL WChief Executive Officer
306827
5.2773%
$255,586.89210
<0.0001%
Gilley Thomasdirector
79972
1.3755%
$66,616.6810
Michel Robert Jdirector
11571
0.199%
$9,638.6410

Historical Insider Profitability vs. Competitors

$489,160
82
-1.83%
$8.77M
$2,870,436
66
17.82%
$316.96M
$8,223,198
64
7.71%
$249.07M
$18,384,887
64
12.58%
$384.43M
$697,501
57
5.94%
$83.09M
$6,770,289
54
1.89%
$3.14B
$26,375,274
46
14.61%
$3.69B
$3,202,069
38
20.40%
$1.42B
$2,486,460
26
11.08%
$3.42B
$30,138,605
26
5.67%
$3.73B
BIO-key International, Inc.
(BKYI)
$263,835
26
-39.51%
$4.84M
$2,878,247
23
0.80%
$6.27B
$7,187,915
17
6.27%
$12.53B
$328,288
14
15.89%
$992.32M
$3,497,862
13
10.85%
$6.72B
$203,408
12
-0.86%
$4.86M
$777,595
8
-5.32%
$892.55M
$2,499
1
69.39%
$5.39M

BKYI Institutional Investors: Active Positions

Increased Positions6+37.5%36,527+12.72%
Decreased Positions6-37.5%266,616-92.81%
New Positions3New34,075New
Sold Out Positions4Sold Out266,567Sold Out
Total Postitions160%57,178-80.1%

BKYI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Citadel Advisors Llc$17.000.34%20,330+20,330New2024-12-31
Virtu Financial Llc$13.000.26%15,493+682+4.61%2024-12-31
Geode Capital Management, Llc$9.000.19%11,195+11,195New2024-12-31
Xtx Topco Ltd$8.000.17%10,223+10,223New2024-12-31
Tower Research Capital Llc (Trc)$6.000.12%6,907+1,701+32.67%2024-12-31
Citigroup Inc$2.000.04%2,550+2,550New2024-12-31
Sbi Securities Co., Ltd.$00.01%300-10-3.23%2025-03-31
Osaic Holdings, Inc.$0<0.01%26200%2024-12-31
Bank Of America Corp /De/$0<0.01%83+69+492.86%2024-12-31
Jpmorgan Chase & Co$0<0.01%4500%2024-12-31

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.